Global stem cell therapy market is estimated to be valued at USD 18.61 Bn in 2025 and is expected to reach USD 78.39 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 22.8% from 2025 to 2032.
To learn more about this report, Request sample copy
Stem cell therapy has witnessed huge adoption in recent years, owing to advancement in regulatory framework governing stem cell research and clinical applications. Rising prevalence of chronic diseases and success of stem cell based therapies to treat conditions such as cancer and blood disorders can drive the market growth. Furthermore, increasing public-private investments to develop innovative stem cell solutions for diseases like myocardial infarction can drive the stem cell therapy market growth during the forecast period. The number of clinical trials involving stem cells has significantly increased in the last few years, indicating the promise of this approach for both rare and common diseases. This is anticipated to provide new opportunities and drive future demand.
Increasing Manufacturing Facility Expansion by Key Market Players
Increasing manufacturing facility expansion by key market players is expected to drive the global stem cell therapy market growth over the forecast period. For instance, in October 2023, Bayer AG, a global pharmaceutical company, announced the opening of its first cell therapy facility in California, U.S., to create the capacity to bring cell therapies to patients on a global scale.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients